U.S. Drug Enforcement Administration (DOJ) · United States

Treasury / DEA Cannabis Schedule III Rescheduling Pending — Marketing Implications

Marketing that mentions cannabis rescheduling must accurately state the current federal status and Section 280E applicability and must not present proposed rescheduling as final, as federal legalization, or as a certain investment catalyst.

DEA NPRM, Schedules of Controlled Substances: Rescheduling of Marijuana, 89 FR 44597 (May 21, 2024) (FR Doc. 2024-11137); 21 U.S.C. 812(b)(3), (c) Schedule I(c)(10); 26 U.S.C. 280E; 12 U.S.C. 5536(a)(1)(B); 15 U.S.C. 45(a)(1); DEA notices of Apr. 28, 2026 (FR Doc. 2026-08177, new hearing; 2026-08178, prior notice withdrawn); final rule FR Doc. 2026-08176 (FDA-approved marijuana products to Schedule III)

What is Treasury / DEA Cannabis Schedule III Rescheduling Pending — Marketing Implications?

Marketing that mentions cannabis rescheduling must accurately state the current federal status and Section 280E applicability and must not present proposed rescheduling as final, as federal legalization, or as a certain investment catalyst. Apply to cannabis banking, lending, investment and cannabis-business assets that discuss federal scheduling, DEA rescheduling or Section 280E.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, investors, business · Cannabis, Banking Deposit Products, Deposit Account, Securities · financial services

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2024-05-21

What does this rule require?

Marketing that mentions cannabis rescheduling must accurately state the current federal status and Section 280E applicability and must not present proposed rescheduling as final, as federal legalization, or as a certain investment catalyst.

How can marketing teams comply?

Apply to cannabis banking, lending, investment and cannabis-business assets that discuss federal scheduling, DEA rescheduling or Section 280E.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Drug Enforcement Administration (DOJ)
Jurisdiction
United States
Official citation
DEA NPRM, Schedules of Controlled Substances: Rescheduling of Marijuana, 89 FR 44597 (May 21, 2024) (FR Doc. 2024-11137); 21 U.S.C. 812(b)(3), (c) Schedule I(c)(10); 26 U.S.C. 280E; 12 U.S.C. 5536(a)(1)(B); 15 U.S.C. 45(a)(1); DEA notices of Apr. 28, 2026 (FR Doc. 2026-08177, new hearing; 2026-08178, prior notice withdrawn); final rule FR Doc. 2026-08176 (FDA-approved marijuana products to Schedule III)
Published
2026-11-16
Effective date
2024-05-21
Channel
all_channels
Products
Cannabis, Banking Deposit Products, Deposit Account, Securities
Audiences
general_audience, general_adults_18plus, customers, investors, business

Frequently asked questions

What is Treasury / DEA Cannabis Schedule III Rescheduling Pending — Marketing Implications?

Marketing that mentions cannabis rescheduling must accurately state the current federal status and Section 280E applicability and must not present proposed rescheduling as final, as federal legalization, or as a certain investment catalyst.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, investors, business · Cannabis, Banking Deposit Products, Deposit Account, Securities · financial services

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2024-05-21

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan